Seeking Alpha

More on Vivus (VVUS): Q4 misses across the board as loss widened as operating expenses soared to...

More on Vivus (VVUS): Q4 misses across the board as loss widened as operating expenses soared to $58.3M in the latest period. In contrast, the company recognized just $2M in product revenue from Qsymia sales. Analysts on average expected sales of around $3M. Shares -2.8% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)